Product
vincristine
Aliases
Oncovin(R)
5 clinical trials
6 indications
Indication
Hodgkin lymphomaIndication
lymphomaIndication
Large B-CellIndication
DiffuseIndication
Brain and Central Nervous System TumorsIndication
NeuroblastomaClinical trial
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma With Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)Status: Active (not recruiting), Estimated PCD: 2027-02-13
Clinical trial
Phase 3 Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects With Previously Untreated Activated B-cell Type Diffuse Large B-cell LymphomaStatus: Completed, Estimated PCD: 2019-03-15
Clinical trial
A Phase III Trial of CHOP Plus Rituximab vs CHOP Plus Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) for Treatment of Newly Diagnosed Follicular Non-Hodgkin's LymphomasStatus: Active (not recruiting), Estimated PCD: 2011-09-01
Clinical trial
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorStatus: Completed, Estimated PCD: 2016-12-01
Clinical trial
Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk NeuroblastomaStatus: Active (not recruiting), Estimated PCD: 2021-10-21